The NF/SG Veterans Healthcare System, Malcolm Randall VA Medical Center, 1601 SW Archer Road, Gainesville, FL 32608 intends to negotiate with Genzyme on a sole source basis pursuant to VAAR 873 & 38 USC 8153 and FAR 6.302-1 to provide specialized haematopathology testing that is not offered in-house, provide timely and accurate invoices for the testing performed, and provide documentation of results via a secured website to the VA; to supply appropriate collection material; supplies and a yearly fee schedule. Genzyme provides technical and professional components for a wide breadth of Flow Cytometry, Cytogenetics, FISH, and Molecular testing, some of which are patented. The characterization of hematopoietic cell populations, including leukemia and lymphomas uses different cell surface and cytoplasmic antibodies. The technique allows for the lineage assignment of cells, maturational assessment of the populations, detection of clonality, and the detection of abnormal antigen expression of hematopoietic cells for diagnosis and monitoring of leukemia and lymphoma. Genzyme is a subsidiary of Lab Core, thus has width range of testing available from parent company and other subsidiaries. Specialized testing such as ABL Kinase Mutation or ALK FISH must be available, and in a timely manner. Reports must be received in a consistent and timely manner via protected electronic format. There should be immediate notification of all delays. A courier service must be provided and available 24 hours a day and 7 days a week as should be a local representative to aid in the troubleshooting potential problems. The proprietary data is: Genzyme has the patent for the needed specialized testing such as P53 mutation analysis. They perform the BRAF testing for melanoma that is required by the FDA as a companion diagnosis. Genzyme has the patent to do the full gene sequencing panel for EGFR tissue testing, while other companies are only able to provide partial sequencing. The North American Industry Classification System (NAICS) number is 325414. This notice is NOT a request for competitive proposals. Parties may identify their interest, accompanied by supporting literature to the Contracting Officer no later than January 03, 2012 at 4:00pm EST. Responses should be sent to
[email protected]. No telephone responses will be accepted. Information received will be for the purpose of determining whether or not to conduct a competitive procurement. The determination to conduct a competitive procurement based on responses to this notice is solely within the discretion of the Contracting Officer.